India to United States: Lorazepam Export Trade Route
India has recorded 23 verified shipments of Lorazepam exported to United States, representing a combined trade value of $1.1M USD. This corridor is served by 2 active Indian exporters, with an average shipment value of $49.9K USD. The leading Indian exporter is APL HEALTHCARE LIMITED, which accounts for 83% of total export value with 19 shipments worth $947.1K USD. On the buying side, XXROBXXDO XXARMXXUSAXX INXX is the largest importer in United States with $454.5K USD in purchases. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to United States Lorazepam corridor is one of India's established pharmaceutical export routes, with 23 shipments documented worth a combined $1.1M USD. The route is dominated by APL HEALTHCARE LIMITED, which alone accounts for roughly 83% of all export value, reflecting the consolidated nature of India's lorazepam manufacturing sector.
Across 2 active suppliers, the average shipment value stands at $49.9K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (67%) and air (16%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.
Shipment activity peaks during April–June, with an average transit time of 26 days port-to-port. The route has recorded an annual growth rate of 21.2%, placing it at rank #10 among India's top lorazepam export destinations globally.
On the import side, key buyers of Indian lorazepam in United States include XXROBXXDO XXARMXXUSAXX INXX, AUROBINDO PHARMA USA INC, ANIP ACQUISTION COMPANY and 2 others. XXROBXXDO XXARMXXUSAXX INXX is the single largest importer with 10 shipments valued at $454.5K USD.
Route Characteristics
- Average transit26 days
- Peak seasonQ2
- Primary modeMulti-modal
- Top portAPIIC LIMITED -NAIDUPETA SEZ
Market Position
- Global rank#10
- Annual growth+21.2%
- Demand growth+19.9%
- Regulatory ease67/100
Top 10 Indian Lorazepam Exporters to United States
Showing top 10 of 2 Indian suppliers exporting Lorazepam to United States, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | APL HEALTHCARE LIMITED Avg $49.8K per shipment | 19 | $947.1K | 82.6% |
| 2 | ESJAY PHARMA PRIVATE LIMITED Avg $50.0K per shipment | 4 | $200.0K | 17.4% |
This table shows the top 10 of 2 Indian companies exporting lorazepam to United States, ranked by total trade value. The listed exporters are: APL HEALTHCARE LIMITED, ESJAY PHARMA PRIVATE LIMITED. APL HEALTHCARE LIMITED is the dominant supplier with 19 shipments worth $947.1K USD, giving it a 83% market share.
Top 10 Lorazepam Importers in United States
Showing top 10 of 5 known buyers in United States receiving Lorazepam shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian lorazepam in United States include XXROBXXDO XXARMXXUSAXX INXX, AUROBINDO PHARMA USA INC, ANIP ACQUISTION COMPANY, THE PURCHASE MANAGER, XXROBXXDO XXARMXXUSAXXNC. The largest importer is XXROBXXDO XXARMXXUSAXX INXX, accounting for $454.5K USD across 10 shipments — representing 40% of all lorazepam imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | XXROBXXDO XXARMXXUSAXX INXX | 10 | $454.5K | 39.6% |
| 2 | AUROBINDO PHARMA USA INC | 8 | $427.0K | 37.2% |
| 3 | ANIP ACQUISTION COMPANY | 2 | $133.3K | 11.6% |
| 4 | THE PURCHASE MANAGER | 2 | $66.7K | 5.8% |
| 5 | XXROBXXDO XXARMXXUSAXXNC | 1 | $65.6K | 5.7% |
Top 10 Lorazepam Formulations Imported by United States
Showing top 10 of 8 product formulations shipped on the India to United States Lorazepam route, ranked by trade value
United States imports a wide range of lorazepam formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — LORAZEPAM TABLETS USP 1MG — accounts for $536.0K USD across 10 shipments. A total of 8 product variants have been identified in the shipment records.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | LORAZEPAM TABLETS USP 1MG | 10 | $536.0K | 46.7% |
| 2 | LORAZEPAM TABLETS USP 0.5MG | 5 | $215.9K | 18.8% |
| 3 | LORAZEPAM TABLETS USP 2MG | 3 | $149.1K | 13.0% |
| 4 | LORAZEPAM 0.5 MG TABLETS(BATCH.NO.P25002A, P25003A ,MFG.DT: JAN-2025, EXP.DT:DEC-2026) | 1 | $74.7K | 6.5% |
| 5 | LORAZEPAM 1MG TABLETS(BATCH.NO.P25006A,MFG.DT: JAN-2025, EXP.DT:DEC-2026,BATCH.P25007A,MFG.DT: FEB-2025,EXP.DT:JAN 2027) | 1 | $58.6K | 5.1% |
| 6 | LORAZEPAM TABLETS USP 1MG 500'S PACK | 1 | $46.1K | 4.0% |
| 7 | LORAZEPAM 0.5 mg TAB./500 TAB/PER BOTTLE(USDEA NO:55Z1D34.DT:10.01.25&CBN NO:P/EXP-10525/2025.DT.05.02.2025 | 1 | $37.3K | 3.2% |
| 8 | LORAZEPAM 1 mg TAB./1000 TAB/PER BOTTLE(USDEA NO:Z7FHZR5.DT:10.01.25&CBN NO:P/EXP-10526/2025.DT.05.02.2025 | 1 | $29.5K | 2.6% |
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Balanced freight mix — 67% sea for bulk, 16% air for urgent orders.
Top Ports of Origin
APIIC LIMITED -NAIDUPETA SEZ handles the highest volume with 11 shipments. Transit time averages 26 days by sea.
Market Dynamics
India's lorazepam exports to United States are driven primarily by a handful of large-scale manufacturers. APL HEALTHCARE LIMITED with 19 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 2 active exporters signals a competitive but concentrated market — buyers in United States benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — APL HEALTHCARE LIMITED, ESJAY PHARMA PRIVATE LIMITED — together account for 100% of total trade value on this route. The average shipment value of $49.9K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as lorazepam tablets usp 0.5mg and lorazepam tablets usp 2mg, suggesting that buyers in United States tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, XXROBXXDO XXARMXXUSAXX INXX is the largest importer with 10 shipments worth $454.5K USD — representing 40% of all lorazepam imports from India on this route.
Route Statistics
- Trade Volume
- $1.1M
- Avg. Shipment
- $49.9K
- Suppliers
- 2
- Buyers
- 5
- Transit (Sea)
- ~26 days
- Annual Growth
- +21.2%
Reverse Direction
United States → India — Lorazepam (Import)Other Lorazepam Routes
Unlock the Full India to United States Lorazepam Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 23 shipments on this route.
Frequently Asked Questions — India to United States Lorazepam Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Lorazepam to United States?
The leading Indian exporters of Lorazepam to United States are APL HEALTHCARE LIMITED, ESJAY PHARMA PRIVATE LIMITED. APL HEALTHCARE LIMITED holds the largest market share at approximately 83% of total trade value on this route.
Q What is the total value of Lorazepam exports from India to United States?
India exports Lorazepam to United States worth approximately $1.1M USD across 23 recorded shipments. The average value per shipment is $49.9K USD.
Q Which ports does India use to ship Lorazepam to United States?
The most active port of origin is APIIC LIMITED -NAIDUPETA SEZ with 11 shipments. Indian exporters primarily use a mix of sea and air freight for this route, with 67% of shipments going by sea and 16% by air.
Q How long does shipping take from India to United States for Lorazepam?
The average transit time for Lorazepam shipments from India to United States is approximately 26 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during April–June.
Q Is the India to United States Lorazepam trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 21.2% with demand growth tracking at 19.9%. The route is ranked #10 among India's top Lorazepam export destinations globally.
Q How many suppliers are active on the India to United States Lorazepam route?
There are currently 2 active Indian suppliers exporting Lorazepam to United States. The market is moderately concentrated with APL HEALTHCARE LIMITED accounting for 83% of total shipment value.
Q Who are the main importers of Lorazepam from India in United States?
The leading importers of Indian Lorazepam in United States include XXROBXXDO XXARMXXUSAXX INXX, AUROBINDO PHARMA USA INC, ANIP ACQUISTION COMPANY, THE PURCHASE MANAGER, XXROBXXDO XXARMXXUSAXXNC. XXROBXXDO XXARMXXUSAXX INXX is the largest buyer with 10 shipments worth $454.5K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to United States export trade corridor identified from Indian Customs (DGFT) records for Lorazepam.
- 2.Supplier/Buyer Matching: 2 Indian exporters and 5 importers in United States matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 23 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
23 Verified Shipments
2 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists